HEMATOLOGIC DISEASES
Clinical trials for HEMATOLOGIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC DISEASES trials appear
Sign up with your email to follow new studies for HEMATOLOGIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Tough-to-Treat bone marrow cancer
Disease control Not yet recruitingThis study tests a combination of two drugs, pacritinib and azacitidine, in 25 people with myelodysplastic syndrome (MDS) at moderate to very high risk. The first part finds the safest dose of pacritinib, and the second part checks how well the combo works. Researchers will also …
Matched conditions: HEMATOLOGIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
5,000 patients to help unravel Immune-Blood link
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults with immune system issues to see how often they also have clonal hematopoiesis (a type of blood cell change) or related blood diseases like VEXAS syndrome. Researchers will track new cases over time to better understand these conditions. No tre…
Matched conditions: HEMATOLOGIC DISEASES
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC